|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/47 | |
| A61K 31/557 | |||
| A61P 27/06 |
| (11) | Patento numeris | 3461484 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18206195.2 |
| Europos patento paraiškos padavimo data | 2014-03-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361787883 P | 2013-03-15 | US |
| (72) |
Kopczynski, Casey, US
Lin, Cheng-Wen, US
Sturdivant, Jill Marie, US
Delong, Mitchell, A, US
|
| (73) |
Aerie Pharmaceuticals, Inc.,
7020 Kit Creek Road, Suite 270 Research Triangle Park P.O. Box 12320, Durham, NC 27709,
US
|
| (54) | DIMESYLATE SALTS OF 4-(3-AMINO-1-(ISOQUINOLIN-6-YLAMINO)-1-OXOPROPAN-2-YL)BENZYL, THEIR COMBINATIONS WITH PROSTAGLANDINS AND THE USE THEREOF IN THE TREATMENT OF OCULAR DISORDERS |
| DIMESYLATE SALTS OF 4-(3-AMINO-1-(ISOQUINOLIN-6-YLAMINO)-1-OXOPROPAN-2-YL)BENZYL, THEIR COMBINATIONS WITH PROSTAGLANDINS AND THE USE THEREOF IN THE TREATMENT OF OCULAR DISORDERS |